AGP Picks
View all

Sci-Tech News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Network.

Press releases published on June 14, 2026

Enterprise Integration Has Become the Modernization Bet Mid-Market Companies Underrate, Says APPSeCONNECT
Gyeonggi Business and Science Accelerator Sets Off Global Scale-Up in Full Swing with the ‘1st Pan-Pan Day.’
Venom AI Launches a Live Mentor That Turns AI Conversations Into Real Products
Research Identifies 5 Best Restaurant POS Platforms Standing Out in Australia in 2026
Holiday Ice, Inc. Highlights Why 2,500 lb Daily Ice Output Fits Mid-Size Food Processors
P1Mitigators Unveils InsureFENCE℠ — First AI-Powered Fencing Insurance Scope Scanner
Dyadica Launches Breakthrough Philolaus AI Driven Brand Strategy Program to Supercharge Brand Strategy and Management
SumGeniusAI Launches AI Copilot and Knowledge Gaps for ChatGenius DM Automation
Z-Text Bug Bounty Goes Live: 7 ZEC On-Chain to Anyone Who Breaks It
Online Community Service For Probation
Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
Stake Launches its Referral Code SHIMA – 200% Bonus and 5% Cashback for New Users in 2026
Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph
Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Share this page:

Sign up for:

Sci-Tech News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.